# UK Oxygen Therapy Equipment Market > UK Oxygen Therapy Equipment Market Research Report: Size, Share, Trend Analysis By Product Type (Continuous Positive Airway Pressure, Nasal Cannulas, Oxygen Concentrators, Liquid Oxygen Systems, Portable Oxygen Cylinders), By Technology (Conventional Oxygen Therapy, Hyperbaric Oxygen Therapy, Ventilation Techniques, Transcutaneous Oxygen Monitoring), By End Use (Home Care, Hospitals, Emergency Services, Long-term Care Facilities) andBy Patient Type (Adult, Pediatric, Geriatric) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 4.04% - **2024:** $ 226.37 Million - **2025:** $ 235.52 Million - **2035:** $ 350 Million - **Key Players:** Philips (NL), ResMed (AU), Invacare (US), Breas Medical (SE), AirSep Corporation (US), OxyGo (US), DeVilbiss Healthcare (US), Nidek Medical (JP) **Report ID:** MRFR/Pharma/52290-HCR · **Pages:** 200 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/uk-oxygen-therapy-equipment-market-54052 --- ## Market Summary ## **UK Oxygen Therapy Equipment Market Overview** **As per MRFR analysis, the UK Oxygen Therapy Equipment Market Size was estimated at 1.41 (USD Billion) in 2023. The UK Oxygen Therapy Equipment Market is expected to grow from 1.43 (USD Billion) in 2024 to 2.18 (USD Billion) by 2035. The UK Oxygen Therapy Equipment Market CAGR (growth rate) is expected to be around 3.873% during the forecast period (2025 - 2035).** ### **Key UK Oxygen Therapy Equipment Market Trends Highlighted** The growth of the UK [**Oxygen Therapy Equipment market**](../../../reports/oxygen-therapy-equipment-market-7516)is being propelled by the rising occurrence of respiratory ailments owing to aging populations and lifestyle diseases. The region continues to struggle with **chronic obstructive pulmonary disease** (COPD) and asthma which increases the need for oxygen therapy services. Enhanced Healthcare services and increased awareness about respiratory care are also some important market factors propelling the growth of this industry. In addition, technological progress is supporting the development of new systems for the delivery of oxygen which improves patient comfort and treatment efficacy. Challenges that can be addressed in the UK market include telehealth remote patient monitoring systems. This has gained popularity over time as it improves patient access and resource allocation effectiveness for the **healthcare provider**. The use of AI and data analytics in the design of oxygen therapy equipment can enhance the patient’s condition by customizing treatment plans which is an exciting prospect for growth. Recently, the increase in **homecare services** and portable oxygen devices has been a focus, indicative of a shift towards a more patient-oriented approach. The pandemic fueled the existing practice of providing oxygen therapy to the patient’s home because health care professionals shifted their focus to creating more portable and easier to use devices. The National Health Service in the UK has acknowledged the need to integrate oxygen therapy treatment within the home, which has further reinforced these tendencies. These tendencies also show that there is even greater demand for **treatment related to respiratory care** in particular. ## **UK Oxygen Therapy Equipment Market Drivers** ### **Increasing Prevalence of Respiratory Diseases** One of the primary drivers of growth in the UK Oxygen Therapy Equipment Market is the rising prevalence of respiratory diseases, particularly Chronic Obstructive Pulmonary Disease (COPD) and asthma. According to the National Health Service (NHS), around 12 million people in the UK are diagnosed with COPD, which is expected to increase as the population ages and lifestyle factors contribute to **respiratory issues**. This increase in patient numbers necessitates enhanced oxygen therapy solutions, leading to significant demand for oxygen therapy devices. The NHS has also reported that respiratory diseases have become one of the leading causes of morbidity and mortality in the UK, thus driving the requirement for better oxygen delivery methods and monitoring systems aimed at improving **patient outcomes**. This growing patient demographic is set to stimulate sustained demand for oxygen therapy equipment, providing a robust growth trajectory for the market. ### **Technological Advancements in Oxygen Therapy Devices** The UK Oxygen Therapy Equipment Market is benefiting from rapid technological advancements in the design and functionality of oxygen delivery systems. Innovations such as **portable oxygen concentrators** and non-invasive ventilation devices are increasingly being adopted. The Medical and Healthcare Products Regulatory Agency (MHRA) has estimated that the market for advanced home-based oxygen therapy devices is projected to grow as a result of these technological advancements. This is crucial in a country like the UK where **home healthcare settings** are becoming increasingly popular, facilitated by the NHS’s emphasis on empowering patients to manage their health at home. As technology continues to evolve, manufacturers are focused on creating devices that are not only more efficient but also user-friendly, promoting wider acceptance and usage among healthcare providers and patients alike. ### **Government Initiatives and Funding for Chronic Care** The UK Government’s ongoing initiatives to support chronic disease management significantly impact the growth of the UK Oxygen Therapy Equipment Market Industry. The NHS Long Term Plan emphasizes the importance of **respiratory disease services**, aiming to improve early diagnosis and ensure access to essential treatments. Increased funding allocations for respiratory health provide healthcare providers with the necessary resources to invest in advanced oxygen therapy equipment. In 2020, the UK Government allocated significant funding to improve respiratory services, reflecting a commitment to tackling major health challenges effectively. This strategic focus not only improves patient health outcomes but also enhances the business environment for oxygen therapy equipment manufacturers, thereby creating favorable market conditions. ### **Growing Geriatric Population** The demographic shift towards an older population in the UK is a crucial driver for the UK Oxygen Therapy Equipment Market Industry. By 2020, over 18% of the UK’s population were aged 65 and older, with projections indicating that this figure will rise significantly over the next decade according to the Office for National Statistics (ONS). Older individuals are more susceptible to chronic respiratory conditions, thereby increasing the demand for oxygen therapy solutions. The rise in **life expectancy**, coupled with an increase in the prevalence of diseases associated with aging, such as cardiovascular and respiratory conditions, propels the need for robust oxygen therapy options tailored to meet the requirements of the elderly. This demographic trend assures manufacturers of a sustainable market for their products, positioned to support an aging population effectively. ## **UK Oxygen Therapy Equipment Market Segment Insights** ### **Oxygen Therapy Equipment Market Product Type Insights** The UK Oxygen Therapy Equipment Market is a crucial segment within the healthcare industry, focusing on various product types that cater to a growing population requiring oxygen therapy. Key components of this market include Continuous Positive Airway Pressure, Nasal Cannulas, Oxygen Concentrators, Liquid Oxygen Systems, and Portable Oxygen Cylinders. Continuous Positive Airway Pressure devices are particularly significant for patients suffering from sleep apnea and other respiratory conditions, and their widespread adoption has contributed to enhancing patient comfort and treatment. Nasal Cannulas, recognized for their ease of use and effectiveness, are commonly employed in both in-hospital and at-home settings, proving indispensable owing to their versatility in delivering oxygen therapy to a broad range of patients. Oxygen Concentrators are also a vital product in this segment, providing a continuous supply of oxygen, thus catering to patients needing long-term care; their popularity is influenced by advancements in technology that allow for more portable and efficient designs. Liquid Oxygen Systems represent another essential aspect as they offer a high-capacity oxygen supply, which is beneficial for both outpatient use and hospital settings. With their compact nature, Portable Oxygen Cylinders enable patients to maintain mobility while receiving necessary oxygen therapy, thus enhancing their quality of life. As the UK continues to experience an increase in respiratory disorders due to an aging population and rising pollution levels, the demand for these **oxygen therapy products** is expected to grow. The increasing awareness about respiratory health, along with the emphasis on home healthcare, are significant factors driving the market. Innovations in design and technology are continuously unfolding, enabling higher efficiency and patient comfort, ultimately propelling the market forward. This evolution presents both challenges and opportunities in terms of regulatory compliance and ensuring widespread accessibility, thus making the Product Type segment of the UK Oxygen Therapy Equipment Market a dynamic and essential area of focus within the **healthcare sector**. ### **Oxygen Therapy Equipment Market Technology Insights** The Technology segment of the UK Oxygen Therapy Equipment Market is diverse, encompassing various approaches to delivering oxygen to patients with respiratory issues. Conventional Oxygen Therapy remains a foundational method, addressing the needs of **chronic obstructive pulmonary disease patients** and other individuals requiring supplemental oxygen. Hyperbaric Oxygen Therapy plays a critical role in treating conditions like carbon monoxide poisoning and decompression sickness, providing profound therapeutic benefits under controlled pressure. Ventilation Techniques, including non-invasive ventilation, are gaining importance in managing acute respiratory failure, enabling better patient outcomes through advanced support systems. Transcutaneous Oxygen Monitoring is increasingly utilized to measure a patient's oxygen levels non-invasively, ensuring continuous and accurate monitoring. This segment is significantly driven by advancements in technology, contributing to market growth and improving patients' quality of life. The UK government recognizes the importance of innovative therapies in healthcare, which fosters investment and development within the market, paving the way for further expansion and improved **treatment options for patients** nationwide. ### **Oxygen Therapy Equipment Market End Use Insights** The UK Oxygen Therapy Equipment Market is segmented based on End Use, encompassing key categories such as Home Care, Hospitals, Emergency Services, and Long-term Care Facilities. Home Care is becoming increasingly significant due to the rising elderly population and the growing preference for in-home medical care, reflecting a shift towards comfort and convenience for patients requiring oxygen therapy. Hospitals continue to be vital centers for oxygen therapy, driven by acute patient needs and the treatment of respiratory conditions, while Emergency Services play a crucial role in providing immediate oxygen supply during critical situations, underscoring the demand for efficient and portable oxygen solutions. Long-term Care Facilities cater to patients requiring sustained oxygen therapy, contributing prominently to the market with the adoption of advanced technologies and monitoring systems. The interplay between these segments is influenced by trends such as the aging demographic, rising chronic respiratory disorders, and heightened healthcare expenditure. This segmentation illustrates the expanding landscape of the UK Oxygen Therapy Equipment Market and highlights the diversity of applications and patient needs within the industry. As healthcare demands continue to evolve, each category demonstrates unique growth drivers and challenges, presenting ample opportunities for innovation and development in the realm of oxygen therapy. ### **Oxygen Therapy Equipment Market Patient Type Insights** The UK Oxygen Therapy Equipment Market segmentation based on Patient Type encompasses diverse demographic groups such as Adults, Pediatrics, and Geriatric patients, each presenting unique requirements and challenges. Adults account for a significant portion of the patient population, primarily due to the prevalence of chronic respiratory diseases like Chronic Obstructive Pulmonary Disease (COPD) and asthma, driving demand for oxygen therapy solutions. The Pediatric segment, while smaller, is increasingly recognized for its necessity, particularly as respiratory conditions among children rise, influencing early intervention strategies. Geriatric patients, often dealing with age-related ailments, are a vital segment, as the UK's aging population continues to grow, highlighting the importance of suitable oxygen therapy to enhance their quality of life. This demographic diversity indicates a robust market growth potential fueled by tailored products and services. Additionally, advancements in technology have prompted a shift toward more portable and user-friendly devices, aligning with the patients’ varying lifestyles. Overall, the integration of these segments into the UK Oxygen Therapy Equipment Market reveals an essential landscape shaped by demographic trends and evolving healthcare needs. ## **UK Oxygen Therapy Equipment Market Key Players and Competitive Insights** The UK Oxygen Therapy Equipment Market is characterized by a dynamic landscape, driven by the increasing prevalence of respiratory diseases, rising geriatric population, and growing awareness about the importance of oxygen therapy in improving health outcomes for patients with respiratory issues. A variety of players operate within this market, each vying for market share through innovation, quality, and strategic partnerships. The competition is evident as companies look to enhance their product offerings, streamline distribution channels, and capitalize on emerging trends such as home healthcare and portable oxygen solutions. This competitive environment necessitates constant monitoring of market developments, technological advancements, and regulatory changes to ensure companies can effectively position themselves and meet the evolving needs of healthcare providers and patients alike. Chart Industries has established a notable presence in the UK Oxygen Therapy Equipment Market, leveraging its expertise in gas separation and cryogenic technology to deliver innovative solutions. The company is widely recognized for its high-quality oxygen delivery systems and storage solutions, which are essential for medical facilities and home care environments. One of the key strengths of Chart Industries in this market is its commitment to research and development, allowing it to consistently introduce cutting-edge products that enhance user experience and patient care. Additionally, the focus on strategic collaborations and partnerships has enabled Chart Industries to expand its market reach while maintaining a reputation for reliability and customer satisfaction in the UK. Drive DeVilbiss Healthcare operates as a significant player in the UK Oxygen Therapy Equipment Market, boasting a diverse portfolio that includes oxygen concentrators, portable oxygen devices, and other related products. The company's presence is marked by its strong distribution network and established relationships with healthcare providers, ensuring accessibility to its high-quality products. Drive DeVilbiss Healthcare is well-known for its commitment to innovation, frequently incorporating user-friendly features and advanced technology into its offerings. The company has been active in pursuing mergers and acquisitions to strengthen its position, allowing it to broaden its product range and enhance its market capabilities within the UK. The synergy created from these strategic moves not only augments its market presence but also solidifies Drive DeVilbiss Healthcare’s reputation as a trusted provider in the oxygen therapy sector, equipping healthcare professionals and patients with reliable solutions for managing respiratory conditions. ### **Key Companies in the UK Oxygen Therapy Equipment Market Include** - Chart Industries - Drive DeVilbiss Healthcare - Fisher and Paykel Healthcare - Air Liquide - Oxywise - Caire Inc - Invacare - Medtronic - Linde - Philips - GrahamField - DeVilbiss Healthcare - Breas Medical - Resmed ### **UK Oxygen Therapy Equipment Market Developments** The UK Oxygen Therapy Equipment Market has seen significant developments in recent months, particularly with the ongoing response to respiratory diseases and the increased focus on home healthcare solutions. Companies such as Chart Industries, Air Liquide, and Fisher and Paykel Healthcare have been ramping up their production capabilities to meet the demands posed by the healthcare sector. Recent months have also highlighted the growing market valuation for companies like Linde and Invacare, which are witnessing an upward trend due to increased investments in healthcare infrastructure and the rising need for oxygen therapy systems. In June 2023, Resmed expanded its portfolio through the acquisition of a technology firm specializing in **home ventilation systems**, enhancing its product lineup within the UK market. Moreover, Medtronic's collaborations for advanced oxygen delivery systems, particularly in the context of chronic respiratory conditions, reflect an industry pivot towards innovative solutions. Notably, the introduction of **telehealth applications** has been on the rise, making oxygen therapy more accessible to patients at home, thereby changing the landscape significantly since the onset of the pandemic in early 2020. ## **UK Oxygen Therapy Equipment Market Segmentation Insights** ### **Oxygen Therapy Equipment Market Product Type Outlook** - Continuous Positive Airway Pressure - Nasal Cannulas - Oxygen Concentrators - Liquid Oxygen Systems - Portable Oxygen Cylinders ### **Oxygen Therapy Equipment Market Technology Outlook** - Conventional Oxygen Therapy - Hyperbaric Oxygen Therapy - Ventilation Techniques - Transcutaneous Oxygen Monitoring ### **Oxygen Therapy Equipment Market End Use Outlook** - Home Care - Hospitals - Emergency Services - Long-term Care Facilities ### **Oxygen Therapy Equipment Market Patient Type Outlook** - Adult - Pediatric - Geriatric ## Market Drivers ### Rising Prevalence of Respiratory Disorders The increasing incidence of respiratory disorders in the UK is a primary driver for the oxygen therapy-equipment market. Conditions such as chronic obstructive pulmonary disease (COPD) and asthma are becoming more prevalent, affecting millions. According to recent health statistics, approximately 1.2 million people in the UK are diagnosed with COPD, leading to a growing demand for oxygen therapy solutions. This trend is likely to continue, as the aging population further exacerbates the situation. The oxygen therapy-equipment market is expected to expand as healthcare providers seek to offer effective treatment options for these patients. The need for portable and home-based oxygen therapy devices is particularly pronounced, as patients prefer to manage their conditions in the comfort of their homes. ### Growing Awareness of Home-Based Oxygen Therapy There is a notable increase in awareness regarding the benefits of home-based oxygen therapy among patients and healthcare providers in the UK. This shift is encouraging more individuals to seek oxygen therapy solutions that can be utilized at home, thereby driving the oxygen therapy-equipment market. Educational campaigns and support from healthcare professionals are playing a crucial role in informing patients about the advantages of managing their respiratory conditions at home. As a result, the demand for portable oxygen concentrators and other home-use devices is likely to rise. The market is expected to witness a surge in product innovations aimed at enhancing user experience and convenience, further propelling growth in the oxygen therapy-equipment market. ### Increased Investment in Healthcare Infrastructure The UK government is making substantial investments in healthcare infrastructure, which is positively impacting the oxygen therapy-equipment market. With a focus on improving patient care and accessibility, funding for hospitals and clinics is on the rise. This investment is likely to enhance the availability of advanced oxygen therapy equipment, ensuring that healthcare facilities are well-equipped to meet patient needs. Furthermore, the National Health Service (NHS) is actively promoting the use of oxygen therapy for various medical conditions, which could lead to an increase in demand for these devices. As a result, the oxygen therapy-equipment market is poised for growth, driven by enhanced healthcare services and improved patient outcomes. ### Technological Innovations in Oxygen Delivery Systems Technological advancements in oxygen delivery systems are significantly influencing the oxygen therapy-equipment market. Innovations such as portable oxygen concentrators, smart oxygen therapy devices, and telehealth integration are transforming how oxygen therapy is administered. These advancements not only improve patient comfort but also enhance the efficiency of oxygen delivery. The introduction of user-friendly interfaces and mobile applications for monitoring oxygen levels is likely to attract more users to these devices. As technology continues to evolve, the oxygen therapy-equipment market is expected to expand, with manufacturers focusing on developing cutting-edge solutions that cater to the needs of patients and healthcare providers alike. ### Supportive Regulatory Environment for Medical Devices The regulatory landscape in the UK is becoming increasingly supportive of medical devices, including those used in the oxygen therapy-equipment market. Regulatory bodies are streamlining approval processes for innovative products, which may encourage manufacturers to invest in research and development. This supportive environment is likely to lead to the introduction of new and improved oxygen therapy devices that meet the evolving needs of patients. Additionally, compliance with stringent safety and efficacy standards is fostering consumer confidence in these products. As a result, The oxygen therapy-equipment market is expected to benefit from a steady influx of innovative solutions that enhance patient care and treatment outcomes. ## Future Outlook The [Oxygen Therapy Equipment Market](https://www.marketresearchfuture.com/reports/oxygen-therapy-equipment-market-7516) is projected to grow at 4.04% CAGR from 2025 to 2035, driven by increasing respiratory diseases, technological advancements, and rising healthcare expenditure. **New opportunities:** - Development of portable oxygen concentrators for home use - Integration of telehealth solutions for remote patient monitoring - Expansion of oxygen therapy services in outpatient settings By 2035, the market is expected to achieve substantial growth, driven by innovation and increased demand. ## Segment Insights ### By Type: Oxygen Concentrators (Largest) vs. Oximeters (Fastest-Growing) In the UK oxygen therapy-equipment market, the segmentation reveals that oxygen concentrators comprise the largest market share, driven by their efficiency and patient-friendly design. Following them, oxygen cylinders also hold significant market presence due to their portability and ease of use. However, oximeters are emerging rapidly, attracting attention for their essential role in monitoring patients' oxygen levels, leading to increased demand in various healthcare settings. Growth trends indicate a shift towards more portable and efficient devices; oxygen concentrators continue to dominate due to technological advancements. In contrast, oximeters are becoming increasingly vital, particularly with telemedicine's rise, as they provide essential data for remote patient management. This dynamic reflects a growing preference for easy-to-use, home-based oxygen therapy solutions, propelled by the aging population and chronic respiratory diseases. Oxygen Concentrators (Dominant) vs. Oximeters (Emerging) Oxygen concentrators stand out as the dominant segment in the UK oxygen therapy-equipment market, favored for their ability to deliver a continuous supply of oxygen, making them ideal for home therapy. They are often equipped with advanced features such as user-friendly interfaces and mobile options, appealing to both patients and caregivers. On the other hand, oximeters are carving their path as an emerging segment, gaining traction as essential tools for at-home health monitoring. Their compact and non-invasive nature makes them increasingly preferred by patients who require precise monitoring of blood oxygen saturation levels, reflecting a shift towards integrated telehealth solutions. ### By Application: Chronic Obstructive Pulmonary Disease (Largest) vs. Sleep Apnea (Fastest-Growing) The UK oxygen therapy-equipment market showcases a diverse distribution among its application segments. Chronic Obstructive Pulmonary Disease (COPD) remains the largest segment, accounting for a significant share due to its prevalence among the aging population. Respiratory Distress and Pulmonary Hypertension also contribute to the market; however, they represent smaller portions compared to COPD and Sleep Apnea, the latter gaining traction due to rising awareness and diagnosis rates. Growth trends in the application segment are influenced by various factors, with Sleep Apnea emerging as the fastest-growing due to increased recognition of its health impacts. The rise in obesity rates and an aging population are key drivers for the COPD segment. Furthermore, technological advancements in treatment options are enhancing patient compliance and outcomes, fueling the expansion of both Sleep Apnea and COPD segments. Chronic Obstructive Pulmonary Disease (Dominant) vs. Sleep Apnea (Emerging) Chronic Obstructive Pulmonary Disease (COPD) is the dominant application in the UK oxygen therapy-equipment market, characterized by a substantial patient base and ongoing needs for management and treatment. This segment is marked by extensive use of long-term oxygen therapy, with patients requiring reliable equipment to improve quality of life. On the other hand, Sleep Apnea is an emerging segment, driven by increasing case identification and the growing adoption of continuous positive airway pressure (CPAP) therapy. While COPD remains a well-established segment, Sleep Apnea’s rapid growth highlights a shift in focus towards more technological solutions, presenting opportunities for innovation and market expansion as healthcare providers look to address this significant health issue. ### By End User: Hospitals (Largest) vs. Home Care Settings (Fastest-Growing) The market share distribution among end users in the UK oxygen therapy-equipment market reveals that hospitals hold the largest share, making them a crucial component in the adoption and utilization of oxygen therapy solutions. Home care settings are rapidly gaining traction, reflecting a significant shift towards at-home healthcare solutions, thereby complementing traditional hospital-based care. Growth trends indicate a steady increase in demand for oxygen therapy, particularly driven by an aging population and rising prevalence of respiratory diseases. Hospitals continue to enhance their technologies, while home care settings are being recognized for their convenience, leading to a growing preference for home-based treatment options. This dual growth indicates a transformative phase in the approach to oxygen therapy providing diverse options for patients. Hospitals (Dominant) vs. Home Care Settings (Emerging) Hospitals represent the dominant market segment in the UK oxygen therapy-equipment market, characterized by advanced infrastructure, extensive resources, and a centralized approach to patient care. They rely on the latest technology and rigorous protocols to ensure optimal patient outcomes, maintaining a strong focus on critical care. On the other hand, home care settings are emerging rapidly as a viable alternative to traditional healthcare facilities. They offer increased flexibility, personalized care, and often lower costs, making them attractive for chronic patients requiring long-term oxygen therapy. As healthcare dynamics evolve, the focus on home care is expected to intensify, with both segments playing pivotal roles in delivering comprehensive oxygen therapy solutions. ### By Distribution Channel: Direct Sales (Largest) vs. Online Sales (Fastest-Growing) In the UK oxygen therapy-equipment market, the distribution of sales among various channels reveals a significant reliance on direct sales, which hold the largest share due to established relationships between manufacturers and healthcare providers. Medical supply distributors also play a crucial role, providing accessibility to products in a broader range of facilities. Online sales, while currently smaller in market share, are gaining traction as more healthcare professionals and patients turn towards digital platforms for convenience and quick access to products. The growth trends in this segment are indicative of a shifting landscape. Direct sales remain dominant due to their proven efficiency, yet the rapid adoption of online sales is noteworthy, particularly driven by the increasing inclination of consumers to purchase healthcare products online. This segment is expected to continue evolving as companies invest in e-commerce capabilities and enhance their online presence to meet changing consumer preferences. Direct Sales (Dominant) vs. Online Sales (Emerging) Direct sales in the UK oxygen therapy-equipment market have established themselves as the dominant force, leveraging long-term relationships with healthcare providers to ensure a steady flow of products. This channel allows manufacturers to have direct control over the supply chain, ensuring quality and timeliness in delivery. On the other hand, online sales, while still emerging, are rapidly gaining ground as consumers embrace the ease and convenience of purchasing medical equipment through digital platforms. The growth of online sales is being propelled by advancements in technology, increased internet penetration, and a growing acceptance of online shopping among healthcare professionals and patients. As these trends continue, the online channel is likely to see significant expansion. ## Competitive Benchmarking The oxygen therapy-equipment market is currently characterized by a dynamic competitive landscape, driven by increasing demand for respiratory support solutions and advancements in technology. Key players such as Philips (NL), ResMed (AU), and Invacare (US) are strategically positioned to leverage innovation and expand their market presence. Philips (NL) focuses on enhancing patient outcomes through digital health solutions, while ResMed (AU) emphasizes cloud-connected devices that facilitate remote monitoring. Invacare (US) is concentrating on broadening its product portfolio to include more portable oxygen solutions, which aligns with the growing trend towards home healthcare. Collectively, these strategies contribute to a competitive environment that prioritizes technological advancement and patient-centric solutions.In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain efficiency. The market appears moderately fragmented, with several players vying for market share. However, the influence of major companies is significant, as they set industry standards and drive innovation. This competitive structure allows for a diverse range of products and services, catering to various patient needs and preferences. In October Philips (NL) announced the launch of a new portable oxygen concentrator designed for enhanced mobility and user-friendliness. This strategic move is likely to strengthen Philips' position in the home healthcare segment, as it addresses the growing demand for lightweight and efficient oxygen delivery systems. The introduction of this product may also enhance patient adherence to therapy, thereby improving overall health outcomes. In September ResMed (AU) expanded its partnership with a leading telehealth provider to integrate remote monitoring capabilities into its oxygen therapy devices. This collaboration is indicative of ResMed's commitment to digital transformation, allowing healthcare providers to monitor patients' respiratory health in real-time. Such integration not only enhances patient engagement but also positions ResMed as a leader in the digital health space, potentially increasing its market share. In August Invacare (US) completed the acquisition of a smaller competitor specializing in innovative oxygen delivery systems. This acquisition is expected to bolster Invacare's product offerings and enhance its competitive edge in the market. By integrating new technologies and expertise, Invacare may improve its operational efficiency and expand its reach within the oxygen therapy segment. As of November current trends in the oxygen therapy-equipment market include a strong emphasis on digitalization, sustainability, and the integration of artificial intelligence (AI) into product offerings. Strategic alliances are increasingly shaping the competitive landscape, enabling companies to pool resources and expertise. Looking ahead, it appears that competitive differentiation will evolve from traditional price-based competition to a focus on innovation, advanced technology, and reliable supply chains. This shift may ultimately lead to improved patient outcomes and a more sustainable market environment. ## Recent News & Developments The UK Oxygen Therapy Equipment Market has seen significant developments in recent months, particularly with the ongoing response to respiratory diseases and the increased focus on home healthcare solutions. Companies such as Chart Industries, Air Liquide, and Fisher and Paykel Healthcare have been ramping up their production capabilities to meet the demands posed by the healthcare sector. Recent months have also highlighted the growing market valuation for companies like Linde and Invacare, which are witnessing an upward trend due to increased investments in healthcare infrastructure and the rising need for oxygen therapy systems. In June 2023, Resmed expanded its portfolio through the acquisition of a technology firm specializing in **home ventilation systems**, enhancing its product lineup within the UK market. Moreover, Medtronic's collaborations for advanced oxygen delivery systems, particularly in the context of chronic respiratory conditions, reflect an industry pivot towards innovative solutions. Notably, the introduction of **telehealth applications** has been on the rise, making oxygen therapy more accessible to patients at home, thereby changing the landscape significantly since the onset of the pandemic in early 2020. ## Report Scope | MARKET SIZE 2024 | 226.37(USD Million) | | --- | --- | | MARKET SIZE 2025 | 235.52(USD Million) | | MARKET SIZE 2035 | 350.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.04% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Philips (NL), ResMed (AU), Invacare (US), Breas Medical (SE), AirSep Corporation (US), OxyGo (US), DeVilbiss Healthcare (US), Nidek Medical (JP) | | Segments Covered | Type, Application, End User, Distribution Channel | | Key Market Opportunities | Integration of advanced telehealth solutions in the oxygen therapy-equipment market enhances patient monitoring and accessibility. | | Key Market Dynamics | Technological advancements and regulatory changes drive innovation in the oxygen therapy-equipment market. | | Countries Covered | UK | ## Frequently Asked Questions **Q: What is the current valuation of the UK oxygen therapy-equipment market?** A: The market valuation was $226.37 Million in 2024. **Q: What is the projected market size for the UK oxygen therapy-equipment market by 2035?** A: The market is projected to reach $350.0 Million by 2035. **Q: What is the expected CAGR for the UK oxygen therapy-equipment market during the forecast period 2025 - 2035?** A: The expected CAGR is 4.04% during the forecast period. **Q: Which segment had the highest valuation in the UK oxygen therapy-equipment market in 2024?** A: Oxygen Concentrators had the highest valuation at $140.0 Million in 2024. **Q: What are the key applications driving the UK oxygen therapy-equipment market?** A: Key applications include Respiratory Distress, Chronic Obstructive Pulmonary Disease, and Sleep Apnea. **Q: Which distribution channel is expected to dominate the UK oxygen therapy-equipment market?** A: Online Sales is expected to dominate with a valuation of $140.0 Million. **Q: Who are the leading players in the UK oxygen therapy-equipment market?** A: Key players include Philips, ResMed, Invacare, and Breas Medical. **Q: What is the valuation range for Oxygen Cylinders in the UK oxygen therapy-equipment market?** A: The valuation range for Oxygen Cylinders was $60.0 Million to $90.0 Million in 2024. **Q: How does the market for Long-term Care Facilities compare to other end users?** A: Long-term Care Facilities had a valuation of $40.0 Million, lower than Hospitals and Home Care Settings. **Q: What is the valuation for the application of Pulmonary Hypertension in the UK oxygen therapy-equipment market?** A: The valuation for Pulmonary Hypertension was $50.0 Million in 2024. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/uk-oxygen-therapy-equipment-market-54052*